Available 7 Days/Week       MON - FRI  8am - 7pm       SAT - SUN  10am – 6pm
Call us (239) 744-2200
Apply Now

Johnson & Johnson vaccine to remain on pause

The Center for Disease Control and Prevention (CDC) said the Johnson & Johnson COVID-19 vaccine will remain on pause as an investigation continues on the recent reports of severe blood clots, NBC News reports.

Experts advisors said they do not yet have enough information to make any new recommendations on the Johnson & Johnson vaccine.

The CDC held a meeting Wednesday with the Advisory Committee on Immunization Practices (ACIP), an independent panel of health experts, outside of the CDC.

Officials agreed the Johnson & Johnson vaccine should remain on pause for now with a final decision to be made in the coming weeks.

The CDC, and the FDA, first recommended the pause Tuesday after six people developed rare but serious blood clots after getting the Johnson & Johnson vaccine shots.

The Food and Drug Administration (FDA) could also change Johnson & Johnson’s emergency use authorization which currently allows anyone 18 and older to receive the vaccine, NBC News reports.

Every US state has temporarily stopped administering the Johnson & Johnson vaccine.

Click here to read more.

The post Johnson & Johnson vaccine to remain on pause appeared first on NBC2 News.


#marcoislandmortgage, #marcoislandmortgagerates, #mortgagemarcoisland, *Top News, Health, Johnson & Johnson, National & World, News, Vaccine

Copyright © 2023 Fidelity Home Group supports Equal Housing Opportunity | All Right Reserved  | NMLS Identifier 1834853. Fidelity Home Group is not affiliated with the Department of Housing and Urban Development (HUD) or the Federal Housing Administration (FHA). Not intended for legal or financial advice, consult your own professionals if such advice is sought. Accessibility Statement  | Consent to Receive Electronic Loan Documents  |  Cookies Policy   |  Disclosures  | Email and Mobile PolicyFair Lending Policy  |  Mortgage Assumptions  |  NMLS Consumer Access  |  Privacy Policy  |  Terms of Use